Mild hypercalcemia: an indication to select 4-dimensional computed tomography scan for preoperative localization of parathyroid adenomas

Am J Surg. 2011 Mar;201(3):334-8; discussion 338. doi: 10.1016/j.amjsurg.2010.08.033.

Abstract

Background: Technetium sestamibi scanning is the most accepted method of imaging used for preoperative localization of parathyroid adenomas. Four-dimensional computed tomography (4D-CT) scanning is a relatively new localization technique that has not been as rigorously evaluated.

Methods: One hundred thirty-five consecutive patients who underwent preoperative sestamibi scanning, 4D-CT scanning, and parathyroidectomy for primary hyperparathyroidism were evaluated. Patient characteristics, parathyroid gland weights, and the probability of having positive preoperative localization were examined.

Results: Four-dimensional computed tomography scanning was significantly more accurate than sestamibi (73% vs 62%, P = .016). In those with serum calcium levels less than 10.8 mg/dL, 4D-CT scanning was significantly more accurate than sestamibi scanning for the quadrant (45% vs 29%, P = .013) and hemisphere (66% vs 48%, P = .012). Also, 4D-CT scanning was more accurate among patients with parathyroid gland weights less than 500 mg (69% vs 45%, P < .001).

Conclusions: Four-dimensional computed tomography scanning provides better preoperative localization than sestamibi scanning, particularly in patients with mild hypercalcemia and smaller parathyroid adenomas.

Publication types

  • Comparative Study

MeSH terms

  • Adenoma / blood
  • Adenoma / complications
  • Adenoma / diagnosis*
  • Adenoma / diagnostic imaging
  • Adenoma / surgery
  • Biomarkers, Tumor / blood*
  • Female
  • Four-Dimensional Computed Tomography
  • Humans
  • Hypercalcemia / etiology*
  • Male
  • Middle Aged
  • Parathyroid Hormone / blood*
  • Parathyroid Neoplasms / blood
  • Parathyroid Neoplasms / complications
  • Parathyroid Neoplasms / diagnosis*
  • Parathyroid Neoplasms / diagnostic imaging
  • Parathyroid Neoplasms / surgery
  • Parathyroidectomy*
  • Preoperative Period
  • Radiopharmaceuticals
  • Technetium Tc 99m Sestamibi
  • Tomography, Emission-Computed, Single-Photon / methods

Substances

  • Biomarkers, Tumor
  • Parathyroid Hormone
  • Radiopharmaceuticals
  • Technetium Tc 99m Sestamibi